This latest patent is the twenty first patent granted to AnPac Bio in the United States.
- This latest patent is the twenty first patent granted to AnPac Bio in the United States.
- We are pleased that AnPac Bio has been granted our first disease treatment patent, whose disease treatment related claims will be licensed to our new cancer treatment joint venture (while future disease treatment only patent applications will be transferred to the cancer treatment joint venture).
- We are also pleased that our cancer treatment joint venture has secured funding to speed up its cancer treatment developments.
- AnPac Bio is a biotechnology company focused on early cancer screening and detection as well as cancer treatment, with 142 issued patents as of March 31, 2021.